Ashford Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,483	Closed	-$1.56M	–	108
2024 Q3	$1.56M	Sell	1,483 -89	-6%	-$99K	0.19%	70
2024 Q2	$1.65M	Hold	1,572	–	–	0.22%	66
2024 Q1	$1.51M	Sell	1,572 -58	-4%	-$55.2K	0.2%	64
2023 Q4	$1.43M	Buy	1,630 +909	+126%	+$749K	0.19%	68
2023 Q3	$593K	Hold	721	–	–	0.09%	76
2023 Q2	$518K	Hold	721	–	–	0.07%	72
2023 Q1	$592K	Hold	721	–	–	0.09%	71
2022 Q4	$520K	Hold	721	–	–	0.08%	73
2022 Q3	$497K	Sell	721 -135	-16%	-$85K	0.08%	79
2022 Q2	$506K	Hold	856	–	–	0.07%	78
2022 Q1	$598K	Hold	856	–	–	0.06%	85
2021 Q4	$541K	Sell	856 -122	-12%	-$75K	0.05%	87
2021 Q3	$592K	Hold	978	–	–	0.05%	87
2021 Q2	$546K	Hold	978	–	–	0.05%	91
2021 Q1	$463K	Sell	978 -1,506	-61%	-$733K	0.04%	90
2020 Q4	$1.2M	Sell	2,484 -506	-17%	-$273K	0.12%	70
2020 Q3	$1.67M	Buy	2,990 +426	+17%	+$258K	0.2%	55
2020 Q2	$1.6M	Buy	2,564 +1,534	+149%	+$871K	0.21%	57
2020 Q1	$503K	Buy	+1,030	New	+$425K	0.09%	72